{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:55:41Z","timestamp":1775840141411,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to assess whether anti-\u03b22-glycoprotein I (\u03b22GPI)\/human leukocyte antigen (HLA)-DR autoantibodies are associated with pregnancy outcomes in women with infertility receiving assisted reproductive technology (ART) in relation to antithrombotic therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this multicenter prospective cohort study, levels of anti-\u03b22GPI\/HLA-DR autoantibodies were measured in 194 women with infertility, who subsequently received embryo transfer (ET). The rates of clinical pregnancy, biochemical pregnancy loss, live birth, and miscarriage were assessed in relation to antibody positivity and antithrombotic treatments. The primary outcome was to evaluate how antithrombotic treatments were associated with pregnancy outcomes in women with anti-\u03b22GPI\/HLA-DR antibodies receiving ART. The treatment modality for the antibody-positive group was determined for each ET at the discretion of the attending physician.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Finally, 30 women in the antibody-positive group and 123 in the antibody-negative group were analyzed. The prevalence of recurrent implantation failure in the antibody-positive group (40.0%, 12\/30) was higher than that in the antibody-negative group (20.3%, 25\/123; p = 0.024). The clinical pregnancy rate per ET tended to be lower in the antibody-positive group than in the antibody-negative group (30.4%, 21\/69 vs 43.6%, 92\/211; p=0.053), while the implantation rate per embryo was significantly lower in the antibody-positive group than in the antibody-negative group (26.3%, 21\/80 vs 39.0%, 92\/236; p=0.040). Among women in the antibody-positive group, low-dose aspirin (LDA), LDA plus unfractionated heparin (UFH), and non-LDA\/non-UFH treatments were given in 30, 5, and 34 ET cases, respectively. The clinical pregnancy (42.9%, 15\/35 ET vs. 17.6%, 6\/34 ET; p = 0.044) and live birth (37.1%, 13\/35 ET vs. 11.8%, 4\/34 ET; p = 0.030) rates were higher in treated-group with LDA\/UFH than non-LDA\/non-UFH group. LDA\/UFH treatment was independently associated with higher clinical pregnancy rates (adjusted odds ratio, 3.34; 95% confidence interval, 1.02\u201312.3; p = 0.047). Immunofluorescent staining showed coordinated expression of \u03b22GPI and HLA-DR antigens on the epithelial cells of the eutopic endometrium in the antibody-positive group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LDA\/UFH treatment may be associated with higher clinical pregnancy and live-birth rates in women positive for anti-\u03b22GPI\/HLA-DR antibodies receiving ART.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1626862","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:29:15Z","timestamp":1763965755000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Pregnancy outcomes in women with anti-\u03b22-glycoprotein I\/human leukocyte antigen-DR autoantibodies receiving assisted reproductive technology: a prospective cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Yosuke","family":"Ono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Ogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Fukushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tanimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Arase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1061766","article-title":"Recurrent implantation failure: A comprehensive summary from etiology to treatment","volume":"13","author":"Ma","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrg3245","article-title":"Human aneuploidy: mechanisms and new insights into an age-old problem","volume":"13","author":"Nagaoka","year":"2012","journal-title":"Nat Rev Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.03.011","article-title":"In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study","volume":"107","author":"Rubio","year":"2017","journal-title":"Fertil Steril"},{"key":"B4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.fertnstert.2013.04.035","article-title":"Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial","volume":"100","author":"Scott","year":"2013","journal-title":"Fertil Steril"},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1755-8166-5-24","article-title":"Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a random- ized pilot study","volume":"5","author":"Yang","year":"2012","journal-title":"Mol Cytogenet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.07.2002","article-title":"Dimin- ished effect of maternal age on implantation after preimplantation genetic diagnosis with array comparative genomic hybridization","volume":"100","author":"Harton","year":"2013","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-018-0414-2","article-title":"Recurrent Implantation Failure-update overview on etiology, diagnosis, treatment and future directions","volume":"16","author":"Bashiri","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1401105111","article-title":"Autoantibodies to IgG\/HLA class II complexes are associated with rheumatoid arthritis susceptibility","volume":"111","author":"Jin","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj9867","article-title":"Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules","volume":"8","author":"Jin","year":"2022","journal-title":"Sci Adv"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/art.41410","article-title":"The \u03b22-Glycoprotein I\/HLA-DR complex is the major autoantibody target in obstetric antiphospholipid syndrome","volume":"72","author":"Tanimura","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-593624","article-title":"\u03b22-Glycoprotein I\/HLA class II complexes are novel autoantigens in antiphospholipid syndrome","volume":"125","author":"Tanimura","year":"2015","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0378(97)00025-9","article-title":"Autoantibodies and infertility: a review of the literature","volume":"33","author":"Van Voorhis","year":"1997","journal-title":"J Reprod Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)57008-3","article-title":"Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization","volume":"62","author":"Geva","year":"1994","journal-title":"Fertil Steril"},{"key":"B14","doi-asserted-by":"publisher","first-page":"103955","DOI":"10.1016\/j.jri.2023.103955","article-title":"Anti- \u03b22-glycoprotein I\/HLA-DR antibody in infertility","volume":"158","author":"Ono","year":"2023","journal-title":"J Reprod Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10958","DOI":"10.3390\/ijms241310958","article-title":"Anti-b2-glycoprotein I\/HLA-DR antibody and adverse obstetric outcomes","volume":"24","author":"Tanimura","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa317","article-title":"Definition, diagnostic and therapeutic options in recurrent implantation failure: an international survey of clinicians and embryologists","volume":"36","author":"Cimadomo","year":"2021","journal-title":"Hum Reprod"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3109\/01443615.2012.717988","article-title":"Do acetyl salicylic acid and terbutaline in combination increase the probability of a clinical pregnancy in patients undergoing IVF\/ICSI","volume":"32","author":"Hanevik","year":"2012","journal-title":"J Obstet Gynaecol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den476","article-title":"Does low-dose aspirin improve pregnancy rate in IVF\/ICSI? a randomized double-blind placebo controlled trial","volume":"24","author":"Dirckx","year":"2009","journal-title":"Hum Reprod"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmn031","article-title":"The potential role of heparin in assisted conception","volume":"14","author":"Nelson","year":"2008","journal-title":"Hum Reprod Update"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)00610-1","article-title":"A randomized, double- blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies","volume":"80","author":"Stern","year":"2003","journal-title":"Fertil Steril"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei020","article-title":"Low- dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: A randomized, placebo-controlled double-blind study","volume":"20","author":"Pakkila","year":"2005","journal-title":"Hum Reprod"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt032","article-title":"Adjunct low-molecular- weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta- analysis","volume":"19","author":"Potdar","year":"2013","journal-title":"Hum Reprod Update"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep086","article-title":"Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial","volume":"24","author":"Urman","year":"2009","journal-title":"Hum Reprod"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1445852","article-title":"Low-dose aspirin and heparin treatment improves pregnancy outcome in recurrent pregnancy loss women with anti-\u03b22-glycoprotein I\/HLA-DR autoantibodies: a prospective, multicenter, observational study","volume":"15","author":"Tanimura","year":"2024","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature11234","article-title":"Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome","volume":"486","author":"Huttenhower","year":"2012","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/ijms23010180","article-title":"The role of genital tract microbiome in fertility: A systematic review","volume":"23","author":"Vitale","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ajog.2016.09.075","article-title":"Evidence that the endometrial microbiota has an effect on implantation success or failure","volume":"215","author":"Moreno","year":"2016","journal-title":"Am J Obstet. Gynecol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1016\/j.cell.2024.08.025","article-title":"Neoself-antigens are the primary target for autoreactive T cells in human lupus","volume":"187","author":"Mori","year":"2024","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3402\/ejpt.v6.25216","article-title":"Analyzing small data sets using Bayesian estimation: the case of posttraumatic stress symptoms following mechanical ventilation in burn survivors","volume":"6","author":"Van de Schoot","year":"2015","journal-title":"Eur J Psychotraumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1626862\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:29:18Z","timestamp":1763965758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1626862\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2025.1626862"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1626862","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"article-number":"1626862"}}